NCT01663155

Brief Summary

The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence of symptomatic advanced lung cancer compared to no screening in former and current smokers with or without a family history of lung cancer who are 40-75 years old.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,424

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2008

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2008

Completed
3.8 years until next milestone

First Posted

Study publicly available on registry

August 13, 2012

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
Last Updated

May 18, 2017

Status Verified

May 1, 2017

Enrollment Period

5.7 years

First QC Date

November 10, 2008

Last Update Submit

May 17, 2017

Conditions

Keywords

lung cancerchest x-rayCT scancomputer aided detection (CAD)screeningsmokers

Outcome Measures

Primary Outcomes (1)

  • The sensitivities of chest x-ray with CAD and chest CT

    The false positive rates of chest x-ray with CAD and chest CT will be compared. The analysis will be based on the study subjects from this prospective study who test positive with chest x-ray and/or CT and who are determined not to have lung cancer during the follow-up period.

    One year after scan

Secondary Outcomes (5)

  • Disease-specific mortality between screening with chest x-ray and CAD versus no screening

    One year after scan

  • All-cause mortality rate between screening with chest x-ray and CAD versus no screening

    One year after scan

  • Length of time between randomization and the incidence of symptomatic advanced lung cancer for screened subjects versus controls

    One year after scan

  • Does lung cancer screening with chest x-rays and computer aided detection (CAD) reduce the incidence of symptomatic advanced lung cancer in a high risk population

    One year after scan

  • The quality of life between screening with chest x-ray and CAD versus no screening.

    One year after scan

Study Arms (1)

all enrolled subjects

Intervention is chest x-ray and CT scan. The chest x-ray image is read first without computer aided detection (CAD) and then a second time with computer aided detection (CAD) the CT scan is read by one reader. Subjects are asked to contribute breath and blood samples.

Device: chest x-ray with or without CAD, lose dose CT scan

Interventions

PA view, low dose CT scan

Also known as: CAD, computer aided detection
all enrolled subjects

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Primary care physicians or any other physician may refer potential candidates. Additionally, subjects may see marketing materials and contact the research team directly. There is no restriction to the area of residence of subjects.

You may qualify if:

  • ages 40-75 years
  • If ages 40-59, then one of the following criteria needs to be met:
  • Current or ex-smoker with \>25 pack years and a family history of lung cancer(parent or sibling) OR
  • current or ex-smoker with \> 25 pack years and COPD OR
  • current or ex-smoker with a \> 35 pack year history
  • If ages 60-75, then one of the following additional criteria needs to be met:
  • Current or ex-smoker with \>25 pack years and a family history of lung cancer (parent or sibling) OR
  • Current or ex-smoker with \>25 pack years and COPD OR
  • Current or ex-smoker with a \>30 pack year history
  • Subject is able to return to Cleveland Clinic for annual follow-up screening
  • Subject is willing to sign a medical release form

You may not qualify if:

  • Current health requires oxygen
  • Have had a chest x-ray or CT of the chest within the last 6 months
  • Previous pneumonectomy
  • Lobectomy of the lung within the last 5 years
  • Diagnosed malignancy within the last 5 years, excluding non-melanoma skin cancer, carcinoma in situ of the cervix and localized prostate cancer
  • A medical condition that would prevent treatment for lung cancer
  • Within the last 6 weeks, one of the following has occured:
  • A new cough or chronic cough that has gotten worse
  • Either new shortness of breath, or any worsening of shortness of breath
  • A cough producing blood
  • Constant chest pain
  • Respiratory infection, pneumonia, or cold
  • Unintentional and unexplained weight loss greater than 5% of total body weight

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Related Publications (2)

  • Mazzone PJ, Obuchowski N, Fu AZ, Phillips M, Meziane M. Quality of life and healthcare use in a randomized controlled lung cancer screening study. Ann Am Thorac Soc. 2013 Aug;10(4):324-9. doi: 10.1513/AnnalsATS.201301-007OC.

  • Mazzone PJ, Obuchowski N, Phillips M, Risius B, Bazerbashi B, Meziane M. Lung cancer screening with computer aided detection chest radiography: design and results of a randomized, controlled trial. PLoS One. 2013;8(3):e59650. doi: 10.1371/journal.pone.0059650. Epub 2013 Mar 20.

Biospecimen

Retention: SAMPLES WITH DNA

Blood draw includes 2 10 mL red top tubes for serum retrieval, and 2 7 mL EDTA tubes for plasma and buffy coat retrieval

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Diagnostic ImagingDiagnosis, Computer-Assisted

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Micheal Phillips, M.D.

    The Cleveland Clinic

    STUDY CHAIR
  • Moulay Meziane, MD

    Chair of Thoracic Imaging

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 10, 2008

First Posted

August 13, 2012

Study Start

September 1, 2008

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

May 18, 2017

Record last verified: 2017-05

Locations